Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients
Authors:
- Daniel Beau StamosDSDaniel Beau Stamos
- Aldo Barajas-OchoaABAldo Barajas-Ochoa
- Jillian E. RaybouldJillian E. Raybould
- 1 April 2023
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 29 (4) , 696-700
Abstract
Nocardia spp. infection should remain on the differential diagnosis of pneumonia in immunocompromised hosts, regardless of co-infections.Keywords
This publication has 19 references indexed in Scilit:
- Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in JapanScientific Reports, 2021
- Diagnosing Disseminated Nocardiosis in a Patient With COVID-19 PneumoniaJournal of Medical Cases, 2021
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort studyThe Lancet Microbe, 2021
- A challenging case of SARS-CoV-2-AIDS and Nocardiosis coinfection from the SMatteo COVID-19 Registry (SMACORE)2021
- State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumoniaInfection, 2021
- Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort studyClinical Microbiology and Infection, 2021
- Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T CellsFrontiers in Immunology, 2019
- Multidrug-resistantNocardia pseudobrasiliensispresenting as multiple muscle abscessesBMJ Case Reports, 2015
- Nocardiosis: Updates and Clinical OverviewMayo Clinic Proceedings, 2012
- NocardiosisJournal of Clinical Microbiology, 2003